Palmitoylation of the V2 vasopressin receptor

Molecular Pharmacology

Volumn 52, Issue 1, 1997, Pages 21-29

  Sadeghi, Hamid M ^a   Innamorati, Giulio ^a   Dagarag, Mirabelle ^a   Birnbaumer, Mariel ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; PALMITIC ACID; VASOPRESSIN V2 RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; VASOPRESSIN RECEPTOR;

ANIMAL CELL; ARTICLE; CELL SURFACE; HUMAN; HUMAN CELL; NONHUMAN; PALMITOYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; STRUCTURE ACTIVITY RELATION; AMINO ACID SEQUENCE; METABOLISM; MOLECULAR GENETICS; MOLECULAR WEIGHT; PHOSPHORYLATION; PHYSIOLOGY;

AMINO ACID SEQUENCE; GTP-BINDING PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; PALMITIC ACID; PHOSPHORYLATION; RECEPTORS, VASOPRESSIN;

EID: 0030610842     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.52.1.21     Document Type: Article

References (26)

1. Olson, E. N. Modification of proteins with covalent lipids. Prog. Lipid Res. 27:177-197 (1988).
2. Linder, M. E., C. Kleuss, and S. M. Mumby. Palmitoylation of G-protein α subunits. Methods Enzymol 250:315-330 (1995).
3. Bonatti, S, G. Migliaccio, and K. Simons. Palmitoylation of viral membrane glycoproteins takes place after exit from the endoplasmic reticulum. J. Biol. Chem. 264:12590-12595 (1989).
4. Ovchinnikov, Y. A., N. G. Abdulaev, and A. S. Bgachuk. Two adjacent cysteine residues in the C-terminal cytoplasmic fragment of bovine rhodopsin are palmitoylated. FEBS Lett. 230:1-5 (1988).
5. Bouvier, M., T. P. Loisel, and T. Hebert. Dynamic regulation of G-protein coupled receptor palmitoylation: potential role in receptor function. Biochem. Soc. Trans. 23:577-581 (1995).
6. 2-adrenergic receptor by the cAMP-dependent protein kinase. J. Biol. Chem. 271:21490-21497 (1996).
7. 341 in the carboxyl tail leads to an uncoupled nonpalmitoylated form of the receptor. J. Biol. Chem. 264:7564-7569 (1989).
8. 2A-adrenergic receptor that eliminate detectable palmitoylation do not perturb receptor-G-protein coupling. J. Biol. Chem. 268:8003-8011 (1993).
9. Kawate, N., and K. M. J. Menon. Palmitoylation of luteinizing hormone/ human choriogonadotropin receptors in transfected cells: abolition of palmitoylation by mutation of Cys-621 and Cys-622 residues in the cytoplasmic tail increases ligand-induced internalization of the receptor. J. Biol. Chem. 269:30651-3065 (1994).
10. s/adenylyl cyclase system. Mol. Endocrinol. 8:886-894 (1994).
11. Sanger, F., S. Nicklen, and A. B. Coulson. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467 (1977).
12. Luthman, H., and G. Magnusson. High efficiency polyoma DNA transfection of chloroquine-treated cells. Nucleic Acids Res. 11:1295-1308 (1983).
13. Keefer, J. R., and L. E. Limbird. The alpha 2A-adrenergic receptor is targeted directly to the basolateral membrane domain of Madin-Darby canine kidney cells independent of coupling to pertussis toxin GTP-binding proteins. J. Biol. Chem. 268:11340-11347 (1993).
14. Bockaert, J., M. Hunzicker-Dunn, and L. Birnbaumer. Hormone-stimulated desensitization of hormone-dependent adenylyl cyclase: dual action of luteinizing hormone on pig graafian follicle membranes. J. Biol. Chem. 251:2653-2663 (1976).
15. Salomon, Y., C. Londos, and M. Rodbell. A highly sensitive adenylate cyclase assay. Anal. Biochem. 58:541-548 (1974).
16. Lowry, O. H., N. J. Rosebrough, O. L. Farr, and R. J. Randall. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275 (1951).
17. 2 vasopressin receptor. Mol. Pharmacol. 50:467-473 (1996).
18. Sadeghi, H. M., G. Innamorati, and M. Birnbaumer. Maturation of receptor proteins in eukaryotic expression systems. J. Signal Transd. Rec. Res. 17:433-445 (1997).
19. Magee, A. I., J. Wootton, and J. De Bony. Detecting radiolabeled lipid-modified proteins in polyacrylamide gels. Methods Enzymol. 250:330-336 (1995).
20. Sadeghi, H. M., G. Innamorati, and M. Birnbaumer. An X-linked NDI mutation reveals a requirement for cell surface V2R expression. Mol. Endocrinol., in press.
21. Innamorati, G., H. Sadeghi, A. N. Eberle, and M. Birnbaumer. Phosphorylation of the V2 vasopressin receptor. J. Biol. Chem. 272:2486-2492 (1997).
22. 2-adrenergic receptor in Sf9 cells. J. Biol. Chem. 267:21733-21737 (1992).
23. Karnik, S. S., K. D. Ridge, S. Bhattacharaya, and H. G. Khorana. Palmitoylation of bovine opsin and its cysteine mutants in COS cells. Proc. Natl. Acad. Sci. USA 90:40-44 (1993).
24. Schulein, R., U. Liebenhoff, H. Muller, M. Birnbaumer, and W. Rosenthal. Properties of the human arginine vasopressin V2 receptor after site-directed mutagenesis of its putative palmitoylation site. Biochem. J. 313: 611-616 (1996).
25. Ross, E. M. Palmitoylation in G-protein signalling pathways. Curr. Biol. 5:107-109 (1995).
26. Loisel, T. P., L. Adam, T. Hebert, and M. Bouvier. Agonist stimulation increases the turnover rate of β2AR-bound palmitate and promotes receptor depalmitoylation. Biochemistry 35:15923-15932 (1996).